Almirall, a global pharmaceutical company member of CataloniaBio & HealthTech, launches its fifth call AlmirallShare to establish collaborations in research and identify new treatments for skin health.

The call seeks partnering opportunities for new assets (chemical entities, biologics and other advanced therapies) in order to maximize their value as innovative therapies.

Scientists all over the world can submit their proposal until 31 October, 2020.

AlmirallShare, led by Maribel Crespo, is responsible for 50% of the private-public collaborations at Almirall. This open innovation platform has received more than 350 proposals since its launch in 2017.

Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream